Don’t miss the latest developments in business and finance.

Marksans Pharma gets EIR from USFDA for its Goa facility

Image
Press Trust of India New Delhi
Last Updated : Oct 09 2017 | 3:48 PM IST
Drug firm Marksans Pharma today said it has received Establishment Inspection Report (EIR) from the US health regulator for its Goa facility.
The company has received EIR from the United States Food and Drug Administration (USFDA) after inspection of its Goa facility from April 3-7, 2017, Marksans Pharma said in a BSE filing.
As per the USFDA, after the completion of an inspection of a facility, an EIR is issued to a company detailing inspectional findings.
Shares of Marksans Pharma were today trading 2.30 per cent higher at Rs 48.85 per scrip in the afternoon trade on BSE.

Disclaimer: No Business Standard Journalist was involved in creation of this content

More From This Section

First Published: Oct 09 2017 | 3:48 PM IST

Next Story